TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Tillotts Pharma AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
47,058
|
36,320
|
41,393 |
| Financial expenses |
132
|
412
|
18 |
| Earnings before taxes |
840
|
388
|
1,040 |
| EBITDA |
711
|
643
|
1,049 |
| Total assets |
24,911
|
17,143
|
14,476 |
| Current assets |
24,886
|
17,120
|
14,454 |
| Current liabilities |
19,104
|
11,788
|
9,412 |
| Equity capital |
4,589
|
4,093
|
3,806 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
22
|
21
|
19 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
18.4%
|
23.9%
|
26.3% |
| Turnover per employee |
2,139
|
1,730
|
2,179 |
| Profit as a percentage of turnover |
1.8%
|
1.1%
|
2.5% |
| Return on assets (ROA) |
3.9%
|
4.7%
|
7.3% |
| Current ratio |
130.3%
|
145.2%
|
153.6% |
| Return on equity (ROE) |
18.3%
|
9.5%
|
27.3% |
| Change turnover |
11,973
|
-5,194
|
12,281 |
| Change turnover % |
34%
|
-13%
|
42% |
| Chg. No. of employees |
1
|
2
|
1 |
| Chg. No. of employees % |
5%
|
11%
|
6% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.